SWOG clinical trial number
S0408
A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin and Bevacizumab for Resectable Colorectal Metastases in the Liver
0% Accrual
Accrual
0%
Closed
Phase
0% Accrual
Accrual
0%
Abbreviated Title
COLORECTAL
Activated
11/15/2006
Closed
04/01/2007
Participants
Limited: SWOG and ECOG Institutions Listed on the Title Page
Research committees
Gastrointestinal Cancer
Treatment
Oxaliplatin
Bevacizumab
Capecitabine
Eligibility Criteria Expand/Collapse
Other Clinical Trials
S2303
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
CTSU/A022101
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
Phase
S2107
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
100% Accrual
Accrual
100%
Open
Phase